Disseminated histoplasmosis presenting as thrombotic microangiopathy

Transfusion

Volumn 46, Issue 7, 2006, Pages 1221-1225

  Dwyre, Denis M ^b   Bell, Adam M ^b   Siechen, Kathleen ^b   Sethi, Sanjeev ^b   Raife, Thomas J ^a  

^a UNIVERSITY OF IOWA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; ATENOLOL; CYCLOSPORIN A; IBUPROFEN; ITRACONAZOLE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS;

ADULT; ARTICLE; CASE REPORT; DISEASE ASSOCIATION; FEMALE; HISTOPLASMOSIS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LABORATORY TEST; MALE; PLASMAPHERESIS; THROMBOTIC THROMBOCYTOPENIC PURPURA; TREATMENT PLANNING;

ADULT; ANTIFUNGAL AGENTS; DIAGNOSIS, DIFFERENTIAL; DISEASE MANAGEMENT; FEMALE; HEMOLYTIC-UREMIC SYNDROME; HISTOPLASMOSIS; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PLASMA EXCHANGE; PURPURA, THROMBOTIC THROMBOCYTOPENIC; THROMBOSIS;

EID: 33746496769     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2006.00873.x     Document Type: Article

References (37)

1. Moake J. Thrombotic microangiopathies. N Engl J Med 2002;347:589-600.
2. Amorosi E, Ultmann J. Thrombotic thrombocytopenic purpura: report of 16 cases and review of the literature. Medicine 1966;45:139-59.
3. Nabhan C, Kwaan H. Current concepts in the diagnosis and management of thrombotic thrombocytopenic purpura. Hematol Oncol Clin North Am 2003, 177-99.
4. Rock G, Shumak K, Buskard N, et al. Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group. N Engl J Med 1991;325: 393-7.
5. Bell W, Braine H, Ness P, et al. Improved survival in thrombocytopenic purpura - hemolytic uremic syndrome. N Engl J Med 1991;325:325-98.
6. Baeyer H. Plasmapheresis in thrombotic microangiopathy-associated syndromes: review of outcome data derived from clinical trials and open studies. Ther Apher 2002;6:320-8.
7. Vesely S, George J, Lämmle B, et al. ADAMTS13 activity in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: relation to presenting features and clinical outcomes in a prospective cohort of 142 patients. Blood 2003;102:60-8.
8. Raife T, Atkinson B, Montgomery RR, et al. Severe deficiency of VWF-cleaving protease (ADAMTS13) activity defines a distinct population of thrombotic microangiopathy patients. Transfusion 2004;44:146-50.
9. Veyradier A, Obert B, Houllier A, et al. Specific von Willebrand factor-cleaving protease in thrombotic microangiopathies: a study of 111 cases. Blood 2001;98:1765-72.
10. George J, Vesely S, Rizvi M. Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. In: Coleman RW, editor. Hemostasis and thrombosis. Philadelphia: Lippincott Williams & Wilkins; 2001. p. 1235-42.
11. Jokela J, Flynn T, Henry K. Thrombotic thrombocytopenic purpura in a human immunodeficiency virus (HIV)-seropositive homosexual man. Am J Hematol 1987;25: 341-3.
12. Meisenberg B, Robinson W, Mosley C, et al. Thrombotic thrombocytopenic purpura in human immunodeficiency (HIV)-seropositive males. Am J Hematol 1988;27:212-5.
13. Marty A, Dumler J, Imes G, et al. Ehrlichiosis mimicking thrombotic thrombocytopenic purpura: case report and pathological correlation. Hum Pathol 1995;26:920-5.
14. Modi K, Dahl D, Berkseth R, et al. Human granulocytic ehrlichiosis presenting with acute renal failure and mimicking thrombotic thrombocytopenic purpura: a case report and review. Am J Nephrol 1999;19:677-81.
15. Chinowsky M. Cerebral falciparum malaria mimicking thrombotic thrombocytopenic purpura. South Med J 1991;84:374-8.
16. Raife T, Montgomery RR. New aspects in the pathogenesis and treatment of thrombotic thrombocytopenic purpura and hemolytic uremic syndrome. Clin Exp Hematol 2001;5:236-61.
17. Moschcowitz E. Hyaline thrombosis of the terminal arterioles and capillaries: a hitherto undescribed disease. Proc N Y Pathol Soc 1924, 21-4.
18. George J, Sadler E, Lammle B. Platelets: thrombotic thrombocytopenic purpura. Am Soc Hematol Educ Prog 2002:315-34.
19. Gottschall JL, Elliot W, Lianos E, et al. Quinine-induced immune thrombocytopenia with hemolytic uremic syndrome: a new clinical entity. Blood 1991;77:306-10.
20. Gottschall JL, Neahring B, McFarland JG, et al. Quinine-induced immune thrombocytopenia with hemolytic uremic syndrome: clinical and serological findings in nine patients and review of literature. Am J Hematol 1994;47:283-9.
21. Holler E, Kolb HJ, Hiller E, et al. Microangiopathy in patients on cyclosporine prophylaxis who developed acute graft-versus-host disease afte HLA-identical bone marrow transplantation. Blood 1989;73:2018-24.
22. Bennet C, Weinberg P, Rozenberg-Ben-Dror K, et al. Thrombotic thrombocytopenic purpura associated with ticlopidine. Ann Intern Med 1998;128:541-4.
23. Shulman H, Striker G, Deeg H, et al. Nephrotoxicity of cyclosporin A after allogeneic marrow transplantation. N Engl J Med 1989;305:1392.
24. Zachariae H, Hansen HE, Olsen TS. Hemolytic uremic syndrome in a patient with systemic sclerosis treated with cyclosporin A. Acta Dermatol Venereol 1992;72:307-9.
25. Katznelson S, Wilkinson A, Rosenthal TR, et al. Cyclosprine-induced hemolytic uremic syndrome: factors that obscure its diagnosis. Transplant Proc 1994;26:2608-9.
26. Mettler N. Isolation of a microtatobiote from patients with hemolytic-uremic syndrome and thrombotic thrombocytopenic purpura and from mites in the United States. N Engl J Med 1969;281:1023-7.
27. Tarantolo SR, Landmark JD, Iwen PC, et al. Bartonella-like erythrocyte inclusion in thrombotic thrombocytopenic purpura. Lancet 1997;350:1602.
28. Wheat L, Kauffman C. Histoplasmosis. Infect Dis Clin North Am 2003;17:1-19.
29. Peddi V, Hariharan S, First M. Disseminated histoplasmosis in renal allograft recipients. Clin Transplant 1996;10: 160-5.
30. Wheat L, Smith E, Sathapatayavongs B. Histoplasmosis in renal allograft recipients. Arch Intern Med 1983;143:703-7.
31. Patel R. Infections in recipients of kidney transplants. Infect Dis Clin North Am 2001;15:901-52.
32. Furlan M, Robles R, Galbusera M, et al. Von Willbrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic uremic syndrome. N Engl J Med 1998; 339:1578-84.
33. Tsai H, Lian EC. Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura. N Engl J Med 1998;339:1385-94.
34. van der Plas M, Schiphorst M, Huizinga E, et al. von Willebrand factor proteolysis is deficient in classic, but not in bone marrow transplantation- associated, thrombotic thrombocytopenic purpura. Blood 1999;93:3798-802.
35. Pham P, Peng A, Wilkinson A, et al. Cyclosporine and tacrolimus- associated thrombotic microangiopathy. Am J Kidney Dis 2000;36:844-50.
36. Saikali J, Truong L, Suki W. Cyclosporine-associated thrombotic microangiopathy in renal allografts. Am J Transplant 2003;3:229-30.
37. Zarifian A, Meleg-Smith S, O'Donovan R, et al. Cyclosporine-associated thrombotic microangiopathy in renal allografts. Kidney Int 1999;55:2457-66.